User profiles for "author:Franklin Johnson"
 | Franklin Johnson ParejasUniversidad de Playa Ancha Verified email at upla.cl Cited by 899 |
Healthy environments for healthy people: bioremediation today and tomorrow.
C Bonaventura, FM Johnson - Environmental health perspectives, 1997 - ehp.niehs.nih.gov
Increases in environmental contamination lead to a progressive deterioration of
environmental quality. This condition challenges our global society to find effective …
environmental quality. This condition challenges our global society to find effective …
[HTML][HTML] Treatment of Fabry's disease with the pharmacologic chaperone migalastat
Background Fabry's disease, an X-linked disorder of lysosomal α-galactosidase deficiency,
leads to substrate accumulation in multiple organs. Migalastat, an oral pharmacologic …
leads to substrate accumulation in multiple organs. Migalastat, an oral pharmacologic …
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT …
Background Fabry disease is an X-linked lysosomal storage disorder caused by GLA
mutations, resulting in α-galactosidase (α-Gal) deficiency and accumulation of lysosomal …
mutations, resulting in α-galactosidase (α-Gal) deficiency and accumulation of lysosomal …
[BOOK][B] Young's practice of urology, based on a study of 12,500 cases
HH Young, DM Davis, FP Johnson - 1926 - books.google.com
Page 1 Page 2 Presented to gM todge by Henry Ransom, MD 8/29/17 UNIVERS THE THE H
VERSITY TY OF OF MIC MICA 1817 LIBRARIES Page 3 Page 4 Page 5 Page 6 Page 7 …
VERSITY TY OF OF MIC MICA 1817 LIBRARIES Page 3 Page 4 Page 5 Page 6 Page 7 …
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial
FG McMahon, K Fujioka, BN Singh… - Archives of Internal …, 2000 - jamanetwork.com
Background Obesity is a highly prevalent medical condition and is commonly accompanied
by hypertension. This study assessed the efficacy and safety of treatment with sibutramine …
by hypertension. This study assessed the efficacy and safety of treatment with sibutramine …
[PDF][PDF] The development of the mucous membrane of the oesophagus, stomach and small intestine in the human embryo
FP Johnson - American Journal of Anatomy, 1910 - scholar.archive.org
The development of the mucous membrane of the digestive tract, although studied for many
years by competent observers, still affords opportunity for further investigation. The present …
years by competent observers, still affords opportunity for further investigation. The present …
[HTML][HTML] Oral migalastat HCl leads to greater systemic exposure and tissue levels of active α-galactosidase A in Fabry patients when co-administered with infused …
DG Warnock, DG Bichet, M Holida, O Goker-Alpan… - PLoS …, 2015 - journals.plos.org
Migalastat HCl (AT1001, 1-Deoxygalactonojirimycin) is an investigational pharmacological
chaperone for the treatment of α-galactosidase A (α-Gal A) deficiency, which leads to Fabry …
chaperone for the treatment of α-galactosidase A (α-Gal A) deficiency, which leads to Fabry …
Binary firefly algorithm for the set covering problem
B Crawford, R Soto, MO Suárez… - 2014 9th Iberian …, 2014 - ieeexplore.ieee.org
The set cover problem, belongs to the branch of combinatorial optimization problems, whose
complexity is exponential theoretically established as NP-complex problems. Consists in …
complexity is exponential theoretically established as NP-complex problems. Consists in …
Binary cat swarm optimization for the set covering problem
B Crawford, R Soto, N Berríos… - 2015 10th Iberian …, 2015 - ieeexplore.ieee.org
The set covering problem belongs to the combinatorial optimization problems, whose
complexity is exponential theoretically established as NP-complex problems. Consists in …
complexity is exponential theoretically established as NP-complex problems. Consists in …
[HTML][HTML] Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders
AE Mulberg, C Bucci-Rechtweg, J Giuliano… - Orphanet Journal of …, 2019 - Springer
Rare or orphan diseases often are inherited and overwhelmingly affect children. Many of
these diseases have no treatments, are incurable, and have a devastating impact on …
these diseases have no treatments, are incurable, and have a devastating impact on …